Navigation Links
Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
Date:5/21/2008

> enriched for the presence of EGFR mutations: Results from phase 2"

Day: Sunday, June 1

Session: Lung Cancer -- Metastatic

Time: 2-6 p.m.

Location: S Hall A1

Poster Number: 42H Abstract Number: 8053

Presenter: Naiyer A Rizvi, MD

Monday, June 2

-- XL647 (EGFR, HER2, VEGFR2) -- Poster & Discussion

"Activity and tolerance of XL647 in NSCLC patients with acquired

resistance to EGFR-TKIs: Preliminary results of a phase 2 trial"

Day: Monday, June 2

Session: Lung Cancer -- Metastatic

Time (Poster): 8 a.m.-noon Location: W375e Lobby

Time (Discussion): Noon-12:15 p.m. Location: W375d

Poster Number: 9 Abstract Number: 8028

Presenter: Vincent A. Miller, MD

-- XL880* (MET, VEGFR2) -- Poster

"Preliminary activity of GSK1363089 (XL880), a dual MET/VEGFR2

inhibitor, in MET amplified poorly differentiated gastric cancer

(PDGC): Interim results of a multicenter phase 2 study"

Day: Monday, June 2

Session: Gastrointestinal (Noncolorectal) Cancer

Time: 8 a.m.-noon

Location: S Hall A1

Poster Number: 33D Abstract Number: 4572

Presenter: Minaxi P. Jhawer, MD

* XL880 was selected by GlaxoSmithKline in December 2007 for further

development and commercialization.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Pharmaceuticals,Inc.announcedtodaythatithasappoint...Abramsbringsmorethan25yearsofdrugdiscoveryanddevel...earmedicineimagingagent,Cardiolite,andworkedfrom19...edicalResearchWorldwide.In1996,Abramsledtheestabli...om1996to2006.AnorMEDdiscoveredanddevelopedMozobil,...
(Date:11/23/2009)...l/--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),asp...elopingandcommercializingsignificantproductsprimar...edthatCraigA.Collard,PresidentandChiefExecutiveOff...nualPiperJaffrayHealthCareConferenceat3:30PMETonWe...YorkCity. ,, AliveaudioandarchivedwebcastofCorn...
(Date:11/20/2009)...- Veridiam (www.veridiam.com) won the prestigious ...the 2009 Workplace Excellence Awards. The awards a...sources Management and recognize innovative and ex...m was one of nine winners, selected from more than...recent awards ceremony. San Diego-based Veridiam i...
(Date:11/20/2009)...RNewswire/ -- Karolinska Development AB today,anno...entered into a,co-investment agreement with the co...arolinska Development and used to invest in the co...d medical technology companies. EIF,has agreed to ... agreement,represents EIF,s largest single investm...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
...fluidic Systems Inc.,(MFSI) announced today that i...production of Microfluidic - Bioagent Autonomous N...th in a series of funded phases by the DHS,Science...ued funding,through March 2009, will allow for low...ed field trials in key locations around the US. In...
...effectively measure,customer satisfaction, follow-...f 3.93 out of 5 among customer service and call ce...conducted by Best Practices, LLC,s GLOBAL,BENCHMAR...ies use this assessment tool, with,companies in th...CSR phone,surveys at all. Instead, companies in th...
... newly established Small Interfering Ribonucleic A...er has been charged with providing high-quality si...nal customers. , HOUSTON...on has chosen Stone Bond Technologies, EE-LIMST...orkflow at its siRNA facility, increasing throughp...
Other Biology Technology:Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 3Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction 2 M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks 2
(Date:11/23/2009)...INE, Calif. -- More than 160 participants gathered...es Keck FUTURES INITIATIVE conference. This year,s...ntists, engineers, and medical researchers to expl... surrounding the emerging field of synthetic biolo...biology at Princeton University and this year,s co...
(Date:11/23/2009)...HAMPAIGN, Ill. A new study provides "incontrovert... Toba on the island of Sumatra about 73,000 years ...iles from the epicenter, researchers report. , T...rs of ash into the atmosphere, leaving a crater (n...kilometers long and 35 kilometers wide. Ash from t...
(Date:11/23/2009)...ERMORE, Calif. - By producing some of the highest ... surfaces, scientists have a deeper understanding ...his research may lead to a new treatment for kidne...ch appears in the Nov. 23 online edition of the jo...nces , explores how peptides interact with mineral...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Good Posture May Inspire Confidence 60927 1Good Posture May Inspire Confidence 60927 2Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representatives Historic Vote to Pass Health Insurance Reform 60922 1Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representatives Historic Vote to Pass Health Insurance Reform 60922 2Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representatives Historic Vote to Pass Health Insurance Reform 60922 3Pennsylvania Jury Awards 242 3 Million to Fayette County Woman in Medical Malpractice Case 60917 1Pennsylvania Jury Awards 242 3 Million to Fayette County Woman in Medical Malpractice Case 60917 2
...vely shrinks uterine fibroids and significantly re...g to the results of a multicenter clinical trial r.... Magnetic resonance-guided, focused ultrasound su...rget fibroids without harming healthy surrounding ... flow in the treated fibroid tissue, which results...
...egan eavesdropping on the phone calls of Americans...ng the tunes sung by their neighbors. , University... sparrows (Melospiza melodia) acquire their song r...g birds choose many of their songs by eavesdroppin...ws. , In laboratory experiments, the young spar...
...the University of Verona and the Institute G. Gasl...ayed by Cytomegalovirus infection in the pathogene...ain cause of morbidity and mortality worldwide. Cl...pertension and high cholesterol levels are known t...isease that also recognises a genetic influence. H...
Other Biology News:Focused ultrasound relieves fibroid symptoms in women 2Eavesdropping comes naturally to young song sparrows 2Eavesdropping comes naturally to young song sparrows 3Cytomegalovirus exacerbates atherosclerosis through an autoimmune mechanism 2
Calcium Flux Agonist Chip, 4-Sipper (coated) from Caliper Life Sciences
On-chip Mobility Shift Chip, 4-Sipper from Caliper Life Sciences
CodeLink Activated Slides from GE Healthcare, formerly Amersham Biosciences
Fluorogenic Chip, 4-Sipper from Caliper Life Sciences
Biology Products: